Article

Prospective assessment of stereotactic ablative surgery for intractable major depression

Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02129, USA.
Biological psychiatry (Impact Factor: 9.47). 06/2008; 64(6):449-54. DOI: 10.1016/j.biopsych.2008.04.009
Source: PubMed

ABSTRACT Despite therapeutic advances for major depression, a subset of patients with this disorder does not respond to conventional treatment. Stereotactic ablative procedures such as anterior cingulotomy have been performed in severely affected, treatment-resistant patients, but the long-term results of such procedures are not fully understood.
Findings are reported for 33 patients with severe treatment-resistant major depression who underwent ablative stereotactic procedures (dorsal anterior cingulotomy followed if necessary by subcaudate tractotomy). Preoperative and long-term postoperative Beck Depression Inventory scores were obtained along with postoperative Clinical Global Improvement values. Both were analyzed to evaluate patients' responses to the surgical procedure(s).
At mean follow-up of 30 months after one or more stereotactic ablative procedures, 11 patients (33.3%) were classified as responders, 14 (42.4%) were partial responders, and 8 (24.2%) did not respond to the surgical procedure(s). Among those (17) who underwent only one procedure, seven (41.2%) responded, whereas six (35.3%) and four (23.5%) showed partial or no response, respectively. Among patients who required multiple surgical procedures, four patients (25%) responded, whereas eight (50%) and four (25%) patients demonstrated partial or no responses, respectively, at long-term follow-up evaluations.
Approximately 75% of depression patients previously resistant to antidepressant therapies received partial or substantial benefit from stereotactic ablative procedures. Those requiring only a single anterior cingulotomy tended to demonstrate more pronounced responses than patients who underwent multiple surgical procedures.

0 Followers
 · 
128 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Advanced treatment options are available from a few tertiary centres for patients with the most severe and treatment-refractory forms of depression and obsessive–compulsive disorder. These treatments include ablative neurosurgery and electrical stimulation procedures directed against different neural targets. They include vagus nerve stimulation (VNS) and deep brain stimulation (DBS). Ablative procedures, such as anterior cingulotomy, are the best established of these alternatives, although the newer electrical stimulation procedures confer potential advantages with respect to surgical morbidity and reversibility. Whilst evidence for VNS as an effective therapy for depression is accruing, DBS remains an experimental treatment, with definitive evidence of efficacy awaited. All neurosurgical procedures used to treat psychiatric disorder should be provided by specialist multidisciplinary teams with expertise in the management of psychiatric disorder by pharmacological and psychological treatment methods. All psychiatric neurosurgical procedures should be subject to detailed long-term clinical audit to determine efficacy and adverse effect burden.
    Psychiatry 04/2009; 8(4):139-143. DOI:10.1016/j.mppsy.2009.01.007
  • [Show abstract] [Hide abstract]
    ABSTRACT: Coupling stimuli and actions with positive or negative outcomes facilitates the selection of appropriate actions. Several brain regions are involved in the development of goal-directed behaviors and habit formation during incentive-based learning. This Review focuses on higher cognitive control of decision making and the cortical and subcortical structures and connections that attribute value to stimuli, associate that value with choices, and select an action plan. Delineating the connectivity between these areas is fundamental for understanding how brain regions work together to evaluate stimuli, develop actions plans, and modify behavior, as well as for elucidating the pathophysiology of psychiatric diseases.
    Neuron 09/2014; 83(5):1019-1039. DOI:10.1016/j.neuron.2014.08.031 · 15.98 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Deep brain stimulation (DBS) applied to the subgenual cingulate cortex (SCC) has been recently investigated as a potential treatment for severe and chronic treatment-resistant depression (TRD). Given its invasive and experimental nature, a comprehensive evaluation of its effectiveness and acceptability is of paramount importance. Therefore, we conducted the present systematic review and exploratory meta-analysis. Methods We searched the literature for English language prospective clinical trials on DBS of the SCC for TRD from 1999 through December 2012 using MEDLINE, EMBASE, PsycINFO, CENTRAL and SCOPUS, and performed a random effects exploratory meta-analysis using Event Rates and Hedges׳ g effect sizes. Results Data from 4 observational studies were included, totaling 66 subjects with severe and chronic TRD. Twelve-month response and remission rates following DBS treatment were 39.9% (95% CI=28.4% to 52.8%) and 26.3% (95% CI=13% to 45.9%), respectively. Also, depression scores at 12 months post-DBS were significantly reduced (i.e., pooled Hedges׳ g effect size=−1.89 [95% CI=−2.64 to −1.15, p<0.0001]). Also, there was a significant decrease in depression scores between 3 and 6 months (Hedges׳ g=−0.27, p=0.003), but no significant changes from months 6 to 12. Finally, dropout rates at 12 months were 10.8% (95% CI=4.3% to 24.4%). Limitations Small number of included studies (most of which were open label), and limited long-term effectiveness data. Conclusions DBS applied to the SCC seems to be associated with relatively large response and remission rates in the short- and medium- to long-term in patients with severe TRD. Also, its maximal antidepressant effects are mostly observed within the first 6 months after device implantation. Nevertheless, these findings are clearly preliminary and future controlled trials should include larger and more representative samples, and focus on the identification of optimal neuroanatomical sites and stimulation parameters.
    Journal of Affective Disorders 04/2014; 159:31–38. DOI:10.1016/j.jad.2014.02.016 · 3.71 Impact Factor

Full-text (2 Sources)

Download
129 Downloads
Available from
May 27, 2014